Commentary: Invasive therapy for hypertrophic obstructive cardiomyopathy: Is it time to reexamine the guidelines? Mazine A, Tam DY, Fremes SE. J Thorac Cardiovasc Surg 2022;164:1511-1513.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Mazine A, Tam DY, Fremes SE. Commentary: Invasive therapy for hypertrophic obstructive cardiomyopathy: Is it time to reexamine the guidelines? J Thorac Cardiovasc Surg 2022;164:1511-1513.
PMID: 33309286